International Neurourology Journal (INJ)

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

All Clinical Practice Should Embrace Research

Khae Hawn Kim

Int Neurourol J. 2023;27(2):77-78. Published online 2023 June 30
DOI: https://doi.org/10.5213/inj.2323edi03

All Clinical Practice Should Embrace Research

Khae Hawn Kim

International Neurourology Journal. 2023;27(2):77-78

Link1

Link2 Link3

Should all unrelated donors for transplantation be matched?

Daniel Weisdorf

Best Practice & Research Clinical Haematology. 2008;21(1):79-83

Link1 Link2

How should we treat the AYA patient with newly diagnosed ALL?

Nicolas Boissel

Best Practice & Research Clinical Haematology. 2017;30(3):175-183

Link1 Link2

Should immunologic strategies be incorporated into frontline ALL therapy?

Cecilie Utke Rank, Wendy Stock

Best Practice & Research Clinical Haematology. 2018;31(4):367-372

Link1 Link2

Cardiovascular disease in lupus patients: Should all patients be treated with statins and aspirin?

Ian N. Bruce

Best Practice & Research Clinical Rheumatology. 2005;19(5):823-838

Link1 Link2

Should all CAR-T therapy for acute lymphoblastic leukemia Be consolidated with allogeneic stem cell transplant?

Alejandro Marinos, Helen E. Heslop

Best Practice & Research Clinical Haematology. 2022;35(4):101414

Link1 Link2

How should we treat older adults with Ph+ adult ALL and what novel approaches are being investigated?

Matthew J. Wieduwilt

Best Practice & Research Clinical Haematology. 2017;30(3):201-211

Link1 Link2

How should we treat a patient with relapsed Ph-negative B-ALL and what novel approaches are being investigated?

Nicola Gökbuget

Best Practice & Research Clinical Haematology. 2017;30(3):261-274

Link1 Link2

How do we measure MRD in ALL and how should measurements affect decisions. Re: Treatment and prognosis?

Xueyan Chen, Brent L. Wood

Best Practice & Research Clinical Haematology. 2017;30(3):237-248

Link1 Link2

Should anyone with Philadelphia chromosome-positive ALL who is negative for minimal residual disease receive a hematopoietic stem cell transplant in first remission?

Mark R. Litzow

Best Practice & Research Clinical Haematology. 2016;29(4):345-350

Link1 Link2